North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 31 to 60 of 86
New
Newer
Older
Oldest
Details
LUP
Section link 19601 Updated: 08.01.05 : NICE TA780: Nivolumab with ipilimumab for untreated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta780...
15/07/2022 09:16:48
(DavidS )
UPD
sitematrix Changed from 0 to
15/07/2022 09:16:37
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
15/07/2022 09:16:37
(DavidS )
UPD
Nivolumab updated
15/07/2022 09:16:37
(DavidS )
LDL
Link Added : NICE TA780: : https://www.nice.org.uk/guidance/ta780
15/07/2022 09:14:29
(DavidS )
UPD
sitematrix Changed from 0 to
15/07/2022 09:13:34
(DavidS )
UPD
isDraft Changed from N to Y
15/07/2022 09:13:34
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metas
15/07/2022 09:13:34
(DavidS )
UPD
Nivolumab NICE TA780
15/07/2022 09:13:34
(DavidS )
UPD
NHSE Changed from N
26/04/2022 11:35:06
(DavidS )
UPD
sitematrix Changed from 0 to
26/04/2022 11:35:06
(DavidS )
UPD
isCyto Changed from 0 to 1
26/04/2022 11:35:06
(DavidS )
UPD
Nivolumab updated
26/04/2022 11:35:06
(DavidS )
UPD
Nivolumab Published from Draft Mode
03/02/2022 12:34:13
(DavidS )
LDL
Link Added : NICE TA746: Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer : https://www.nice.org.uk/guidance/ta746
03/02/2022 11:23:47
(DavidS )
UPD
sitematrix Changed from 0 to
03/02/2022 11:23:21
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
03/02/2022 11:23:21
(DavidS )
UPD
Nivolumab NICE TA746
03/02/2022 11:23:21
(DavidS )
LDL
Link Added : NICE TA736: Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy : https://www.nice.org.uk/guidance/ta736
03/02/2022 11:01:56
(DavidS )
UPD
sitematrix Changed from 0 to
03/02/2022 11:01:27
(DavidS )
UPD
isDraft Changed from N to Y
03/02/2022 11:01:27
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
03/02/2022 11:01:27
(DavidS )
UPD
Nivolumab NICE TA736
03/02/2022 11:01:27
(DavidS )
UPD
sitematrix Changed from 0 to
16/12/2021 15:00:21
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
16/12/2021 15:00:21
(DavidS )
UPD
Nivolumab uopdated
16/12/2021 15:00:21
(DavidS )
LDL
Link Added : NICE TA716: Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency : https://www.nice.org.uk/guidance/ta716
16/12/2021 15:00:00
(DavidS )
UPD
sitematrix Changed from 0 to
16/12/2021 14:59:27
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
16/12/2021 14:59:27
(DavidS )
UPD
Nivolumab NICE TA716
16/12/2021 14:59:27
(DavidS )